| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8235719 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 7 Pages |
Abstract
The results of this study have shown that helical tomotherapy is safe and feasible without major toxicities for the treatment of advanced HCC and results in excellent tumor control and a potential survival benefit. This approach is expected to be a useful palliative option for selected HCC patients with metastases.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jeong Won M.D., Chul Seung M.D., Chan Ran M.D., Chang Wook M.D., Si Hyun M.D., Jong Young M.D., Seung Kew M.D., Chi Wha M.D., Hyun Suk M.D., Ihl Bong M.D.,